Compare NOTV & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | VHC |
|---|---|---|
| Founded | 1974 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 79.2M |
| IPO Year | 1997 | 1999 |
| Metric | NOTV | VHC |
|---|---|---|
| Price | $0.67 | $18.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 16.2K |
| Earning Date | 02-04-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $513,024,000.00 | $106,000.00 |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $45.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.54 | ★ 2020.00 |
| 52 Week Low | $0.66 | $3.68 |
| 52 Week High | $6.48 | $29.00 |
| Indicator | NOTV | VHC |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 45.03 |
| Support Level | $0.79 | $18.21 |
| Resistance Level | $0.86 | $22.27 |
| Average True Range (ATR) | 0.07 | 1.89 |
| MACD | -0.00 | -0.28 |
| Stochastic Oscillator | 6.69 | 29.59 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.